• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Better adherence to an energy reduced Mediterranean diet with more support

byRicha SharmaandDaniel Fisher
October 17, 2019
in Cardiology, Chronic Disease, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this preliminary analysis of an ongoing randomized control trial, participants assigned to an energy-reduced Mediterranean diet with counseling and physical activity showed better adherence to the Mediterranean diet than those who only received instructions to undergo a traditional Mediterranean diet.

2. Energy-reduced Mediterranean diets led to greater improvement in cardiovascular risk factors.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Obesity is commonly linked to both poorer short and long-term health conditions. Nutritional and behavioral modifications may be the most favorable solution to this key issue.  However, programs to increase adherence to such a lifestyle modification are still not optimal. In this randomized control trial, participants in the intervention group that encouraged the energy-reduced Mediterranean diet, physical activity, and had behavioral support displayed significant improvement in diet adherence than those who were told to follow a Mediterranean diet. After 12 months, diet quality, energy intake, and cardiovascular risk factors were also noted to be improved in the intervention group.

The energy-reduced Mediterranean diet program was supported by individual and group counseling that likely led to better diet adherence than the control group. Though the preliminary data here suggest improvement in adherence and health with such an approach, it is unclear the magnitude of this benefit long-term and how cost-effective such an intensive approach would be.

Click to read the study in JAMA

RELATED REPORTS

Significant body weight reduction with cagrilintide-semaglutide therapy

Energy-reduced Mediterranean diet with increased physical activity may significantly reduce risk of type 2 diabetes

#VisualAbstract: Once-weekly Semaglutide Reduces Body Weight in People with Obesity

Relevant Reading: The Mediterranean diet and cardiovascular health

In-Depth [randomized control trial]: The PREDIMED-Plus trial involved 23 Spanish National Health System research centers in Spain and randomized 6874 participants into this multicenter, parallel-group, single-blind clinical trial between September 2013 and December 2016. The eligibility was determined based on age (males 55-75 years of age and females 60-75 years of age), health (no cardiovascular disease at baseline), BMI (27-40 at baseline), and a minimum of 3 criteria for Metabolic Syndrome. A traditional Mediterranean diet with patient only receiving recommendations was assigned to  the control arm. An energy-reduced Mediterranean diet guided by dietitians with promotion of physical activity and behavioral support for weight loss was assigned to intervention arm.  The evaluation of long-term effects of a lifestyle in the intervention group was conducted by trained dietitians by means of in-person interviews, group sessions, and monthly phone-calls.  The mean [SD] age was 65.0 [4.9] years, where 52% of the participants were men (n=3406). The exclusion rate was estimated at 4%, with a total of 6583 participants completed the 12-month follow-up. The mean (SD) er-MedDiet score was 8.5 (2.6) at baseline and 13.2 (2.7) at 12 months in the intervention group (difference 4.7; CI95 4.6 to 4.8). The control group was reported to be 8.6 (2.7) at baseline and 11.1 (2.8) at 12 months (difference 2.5; CI95 2.3 to 2.6; between-group difference 2.2; CI95 2.1-2.4). Overall, the intervention group reported significantly higher adherence to the diet after the course of 12 months, as compared to the control group as well as better energy intake and cardiovascular risk factor markers (p < 0.05).

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiovascular diseasediet adherenceMedDiet scoremediterranean dietobesity
Previous Post

Quick Take: Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis

Next Post

#VisualAbstract: Personalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention

RelatedReports

Cardiology

Significant body weight reduction with cagrilintide-semaglutide therapy

August 29, 2025
Mediterranean diet may reduce age-related neurocognitive decline
Endocrinology

Energy-reduced Mediterranean diet with increased physical activity may significantly reduce risk of type 2 diabetes

August 28, 2025
#VisualAbstract: Once-weekly Semaglutide Reduces Body Weight in People with Obesity
StudyGraphics

#VisualAbstract: Once-weekly Semaglutide Reduces Body Weight in People with Obesity

August 27, 2025
Parental conceptions of weight are becoming increasingly inaccurate
Cardiology

Tirzepatide leads to greater weight loss than semaglutide among adults with obesity

August 26, 2025
Next Post
#VisualAbstract: Personalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention

#VisualAbstract: Personalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention

Nivolumab may be effective in platinum-resistant ovarian cancer

Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial

2 Minute Medicine Rewind October 14, 2019

Development of Anti-Drug Antibodies to Infliximab (Remicade®) and Adalimumab (Humira®) in Patients With Crohn’s Disease

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Moderate to severe TBI is associated with elevated malignant brain tumor risk
  • 2 Minute Medicine Rewind September 1, 2025
  • Significant body weight reduction with cagrilintide-semaglutide therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.